Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 23;20(10):19406-32.
doi: 10.3390/molecules201019406.

Effects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme Cells

Affiliations
Review

Effects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme Cells

Marko Vidak et al. Molecules. .

Abstract

Quercetin, catechins and proanthocyanidins are flavonoids that are prominently featured in foodstuffs and dietary supplements, and may possess anti-carcinogenic activity. Glioblastoma multiforme is the most dangerous form of glioma, a malignancy of the brain connective tissue. This review assesses molecular structures of these flavonoids, their importance as components of diet and dietary supplements, their bioavailability and ability to cross the blood-brain barrier, their reported beneficial health effects, and their effects on non-malignant glial as well as glioblastoma tumor cells. The reviewed flavonoids appear to protect glial cells via reduction of oxidative stress, while some also attenuate glutamate-induced excitotoxicity and reduce neuroinflammation. Most of the reviewed flavonoids inhibit proliferation of glioblastoma cells and induce their death. Moreover, some of them inhibit pro-oncogene signaling pathways and intensify the effect of conventional anti-cancer therapies. However, most of these anti-glioblastoma effects have only been observed in vitro or in animal models. Due to limited ability of the reviewed flavonoids to access the brain, their normal dietary intake is likely insufficient to produce significant anti-cancer effects in this organ, and supplementation is needed.

Keywords: bioavailability; blood-brain barrier; catechins; dietary supplements; flavonoids; food; glial cells; glioblastoma multiforme; proanthocyanidins; quercetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) General structural formula of flavonols; (B) structural formula of quercetin (R = OH) and kaempferol (R = H).
Figure 2
Figure 2
(A) General structural formula of flavan-3-ols; (B) (+)-catechin (2R,3S), the more common of the two catechin enantiomers; (C) gallate moiety; (D) Substituents of catechin derivatives.
Figure 3
Figure 3
(A) Dimeric A type procyanidin (epicatechin-catechin dimer) with C-4→C-8 linkage and C-2→O→C-7 ether bond. Red numbering: epicatechin moiety; green: catechin moiety; (B) dimeric B type procyanidin (epicatechin-catechin) with C-4→C-8 linkage. Red: epicatechin moiety; green: catechin moiety; (C) dimeric B type procyanidin (epicatechin-epicatechin) with C-4→C-6 linkage; (D) dimeric B type prodelphinidin (EGC-catechin) with C-4→C-8 linkage. Red: EGC; green: catechin. Additional OH group at 5′ is marked; (E) dimeric A type propelargonidin (epiafzelechin-afzelechin) with C-4→C-8 and C-2→O→C-7 bonds. Red: epiafzelechin; green: afzelechin. Note the lack of OH groups at the both 3′ positions; (F) general structural formula of anthocyanidins.

References

    1. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 who classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. doi: 10.1007/s00401-007-0243-4. - DOI - PMC - PubMed
    1. Johnson D.R., O’Neill B.P. Glioblastoma survival in the united states before and during the temozolomide era. J. Neurooncol. 2012;107:359–364. doi: 10.1007/s11060-011-0749-4. - DOI - PubMed
    1. Eyler C.E., Rich J.N. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol. 2008;26:2839–2845. doi: 10.1200/JCO.2007.15.1829. - DOI - PMC - PubMed
    1. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. doi: 10.1038/35102167. - DOI - PubMed
    1. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G., Pilozzi E., Larocca L.M., Peschle C., de Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 2006;13:1238–1241. doi: 10.1038/sj.cdd.4401872. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources